What is LOPJLB’s current signal on RNAZ?

LOPJLB’s latest quantitative signal on TransCode Therapeutics, Inc. (RNAZ) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is RNAZ in?

TransCode Therapeutics, Inc. (RNAZ) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is TransCode Therapeutics, Inc. based / listed?

TransCode Therapeutics, Inc. is based in US, listed on NASDAQ.

TransCode Therapeutics, Inc. (RNAZ)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.71-2.84%Close

SELLRECOVERY · day 4

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $2M
Beta: 1.26
P/E (TTM): -0.04

Short % float: 7.09%
Days to cover: 1.8
SI change: +33.5%

1W: +10.32%
1M: -3.93%

vs SPY 1W: +8.76%
vs SPY 1M: -5.70%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

TransCode Therapeutics, Inc. is a biopharmaceutical firm dedicated to pioneering and marketing therapeutic agents and diagnostic tools specifically aimed at combating and detecting metastatic disease. Central to its pipeline is TTX-MC138, a lead therapeutic compound currently…

Employees: 12
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 950.3K
Float: 91.1%

transcodetherapeutics.com ↗

Key executives

Philippe Calais — Chief Executive Officer & Executive Chairman of the Board

Thomas A. Fitzgerald — Chief Financial Officer, President, Vice President of Administration & Director

Zdravka Medarova — Scientific Co-Founder & Chief Scientific Officer

SEC filings

EDGAR · CIK 18296350 · RNAZ

Analyst consensus

Buy

Bullish1100.0%

Neutral00.0%

Bearish00.0%

Last$1.71

Key stats

Prediction markets

Company news